Information
-
Version 2 * National Standard 7 - Blood Management Standard
-
Client / Site
-
Conducted on
-
Conducted by:
-
Personnel who participated in the gathering of specific evidence for this Standard
-
Address / Location
Standard 7 - Audit Report
CLINICAL GOVERNANCE AND QUALITY IMPROVEMENT TO SUPPORT BLOOD MANAGEMENT
Integrating clinical governance
-
7.1 Clinicians use the safety and quality systems from the Clinical Governance Standard when:<br>a. Implementing policies and procedures for blood management<br>b. Managing risks associated with blood management<br>c. Identifying training requirements for blood management
Applying quality improvement systems
-
7.2 The health service organisation applies the quality improvement system from the Clinical Governance Standard when:<br>a. Monitoring the performance of the blood management system<br>b. Implementing strategies to improve blood management and associated processes<br>c. Reporting on the outcomes of blood management
Partnering with consumers
-
7.3 Clinicians use organisational processes from the Partnering with Consumers Standard when providing safe blood management to:<br>a. Actively involve patients in their own care<br>b. Meet the patient’s information needs<br>c. Share decision-making
PRESCRIBING AND CLINICAL USE OF BLOOD AND BLOOD PRODUCTS
Optimising and conserving patients’ own blood
-
7.4 Clinicians use the blood and blood products processes to manage the need for, and minimise the inappropriate use of, blood and blood products by:<br>a. Optimising patients’ own red cell mass, haemoglobin and iron stores<br>b. Identifying and managing patients with, or at risk of, bleeding<br>c. Determining the clinical need for blood and blood products, and related risks
Documentation
-
7.5 Clinicians document decisions relating to blood management, transfusion history and transfusion details in the healthcare record
Prescribing and administering blood and blood products
-
7.6 The health service organisation supports clinicians to prescribe and administer blood and blood products appropriately, in accordance with national guidelines and national criteria
Reporting adverse events
-
7.7 The health service organisation uses processes for reporting transfusionrelated adverse events, in accordance with national guidelines and criteria
-
7.8 The health service organisation participates in haemovigilance activities, in accordance with the national framework
MANAGING THE AVAILABILITY AND SAFETY OF BLOOD AND BLOOD PRODUCTS
Storing, distributing and tracing blood and blood products
-
7.9 The health service organisation has processes:<br>a. That comply with manufacturers’ directions, legislation, and relevant jurisdictional requirements to store, distribute and handle blood and blood products safely and securely <br>b. To trace blood and blood products from entry into the organisation to transfusion, discard or transfer
Availability of blood
-
7.10 The health service organisation has processes to:<br>a. Manage the availability of blood and blood products to meet clinical need<br>b. Eliminate avoidable wastage<br>c. Respond in times of shortage
